Andrew A. Kanner

Effect of Tumor-Treating Fields Plus Maintenance Temozolomide vs Maintenance Temozolomide Alone on Survival in Patients With Glioblastoma

Roger Stupp, Sophie Taillibert, Andrew A. Kanner et al. · JAMA · 2017 · 2.5K citations · Full text

Maintenance Therapy With Tumor-Treating Fields Plus Temozolomide vs Temozolomide Alone for Glioblastoma

Roger Stupp, Sophie Taillibert, Andrew A. Kanner et al. · JAMA · 2015 · 1.2K citations · Full text

Preservation of Memory With Conformal Avoidance of the Hippocampal Neural Stem-Cell Compartment During Whole-Brain Radiotherapy for Brain Metastases (RTOG 0933): A Phase II Multi-Institutional Trial

Vinai Gondi, Stephanie L. Pugh, Wolfgang A. Tomé et al. · Journal of Clinical Oncology · 2014 · 1.1K citations · Full text

NovoTTF-100A versus physician’s choice chemotherapy in recurrent glioblastoma: A randomised phase III trial of a novel treatment modality

Roger Stupp, Eric T. Wong, Andrew A. Kanner et al. · European Journal of Cancer · 2012 · 828 citations

Effect of Tumor-Treating Fields Plus Maintenance Temozolomide vs Maintenance Temozolomide Alone on Survival in Patients With Glioblastoma

Roger Stupp, Sophie Taillibert, Andrew A. Kanner et al. · Zurich Open Repository and Archive (University of Zurich) · 2017 · 641 citations

Neuro-oncology, Oncology, Medicine +9